LUND,
Sweden, Aug. 11, 2022 /PRNewswire/ -- The
California Department of Public Health has granted Immunovia, Inc.,
the American subsidiary of Immunovia AB (Nasdaq :IMMNOV)
(Stockholm: IMMNOV), a Clinical
and Public Health Laboratory license, allowing physicians in
California to order the IMMray
PanCan-d test for their patients.
"People at risk for pancreatic cancer need better tools for
early detection. We are thrilled that this approval enables us to
make IMMray PanCan-d available to clinicians in California who care for those at risk." says
Jeff Borcherding, Chief Executive
Officer of Immunovia, Inc.
For more information, please contact:
Philipp Mathieu
CEO and President
Email: philipp.mathieu@immunovia.com
Karin Almqvist Liwendahl
Chief Financial Officer
Email: karin.almqvist.liwendahl@immunovia.com
The information was submitted for publication on August 10, 2022, at 09:55
am CET.
About Immunovia
Immunovia AB is a diagnostic company with the vision to
revolutionize blood-based diagnostics and increase survival rates
for patients with cancer.
Our first product, IMMray™ PanCan-d is the only blood test
currently available specifically for the early detection of
pancreatic cancer. The test has unmatched clinical performance.
Commercialization of IMMray™ PanCan-d started in August 2021 in the USA and IMMray™ PanCan-d is offered as a
laboratory developed test (LDT) exclusively through Immunovia, Inc.
For more information see: www.immunoviainc.com.
Immunovia collaborates and engages with healthcare providers,
leading experts and patient advocacy groups globally to make this
test available to all high-risk pancreatic cancer groups.
The USA, the first market in
which IMMray™ PanCan-d is commercially available, is the world's
largest market for the detection of pancreatic cancer with an
estimated value of more than USD 4
billion annually.
Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For
more information, please visit www.immunovia.com.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/immunovia-ab/r/immunovia--inc--issued-clinical-and-public-health-laboratory-license-from-california-dept-of-public-,c3612734
The following files are available for download:
https://mb.cision.com/Main/13121/3612734/1613663.pdf
|
Press release
(PDF)
|
View original
content:https://www.prnewswire.com/news-releases/immunovia-inc-issued-clinical-and-public-health-laboratory-license-from-california-dept-of-public-health-for-immray-pancan-d-test-301604178.html
SOURCE Immunovia AB